AstraZeneca
oncology highlights leading new wave of oncology molecules encouraging early phase data for four phase trials announced rapidly advancing programmes into phase with potential to combine with | AstraZeneca
Company
Deck Type
Deck date
November 2023
Slide
18 of 45
Related slides by other companies
Investor Presentation
November 2023
Investor Presentation
January 2024
Investor Presentation
May 2023
Investor Presentation
August 2023
Other recent decks by AstraZeneca
Results
February 2024
Investor Conference
January 2024
Results
July 2023
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io